| Mar 26 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 6.51K | $ 20.00K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 6.51K | $ 20.00K |
| Operating Income | $ -65.41K | $ -47.57K | $ -266.34K | $ -126.32K | $ -21.93K |
| EBITDA | $ -65.41K | $ -47.96K | $ -100.91K | $ 98.47K | $ 253.52K |
| Net Income | $ -87.21K | $ -49.02K | $ -269.65K | $ -130.66K | $ 16.95K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.28K | $ 287.00 | $ 8.38K | $ 1.60K | $ 2.65K |
| Total Assets | $ 504.51K | $ 501.28K | $ 509.38K | $ 308.86K | $ 214.30K |
| Total Debt | $ 357.45K | $ 272.03K | $ 268.47K | $ 238.45K | $ 39.61K |
| Net Debt | $ 356.17K | $ 271.74K | $ 260.09K | $ 236.85K | $ 36.96K |
| Total Liabilities | $ 688.09K | $ 543.26K | $ 502.34K | $ 282.17K | $ 56.95K |
| Stockholders' Equity | $ -183.57K | $ -41.98K | $ 7.04K | $ 26.69K | $ 157.35K |
| Cash Flow | |||||
| Free Cash Flow | $ -56.19K | $ -11.65K | $ -273.24K | $ -196.76K | $ -35.31K |
| Operating Cash Flow | $ -56.19K | $ -11.65K | $ -273.24K | $ -196.76K | $ -35.31K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 58.13K | $ 3.55K | $ 280.02K | $ 195.71K | $ 37.74K |
Health Advance Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.